Research Topics
| Raymond C RosenSummaryAffiliation: New England Research Institutes Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Sexual well-being, happiness, and satisfaction, in women: the case for a new conceptual paradigmRaymond C Rosen
New England Research Institutes, Watertown, Massachussetts 02472, USA
J Sex Marital Ther 34:291-7; discussion 298-307. 2008..In this commentary article, we review recent findings and propose a new conceptual model for addressing these effects in controlled studies...
Registry of Hypogonadism in Men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal menRaymond C Rosen
New England Research Institutes, Inc, Watertown, MA 02471, USA
Aging Male 16:1-7. 2013..The Registry of Hypogonadism in Men (RHYME) is a multi-national patient registry assessing prostate health and other outcomes associated with testosterone treatment in men...
Sexual desire problems in women seeking healthcare: a novel study design for ascertaining prevalence of hypoactive sexual desire disorder in clinic-based samples of U.S. womenRaymond C Rosen
Department of Epidemiology, New England Research Institutes, Inc, Watertown, Massachusetts 02472, USA
J Womens Health (Larchmt) 21:505-15. 2012..The current study aimed to determine the prevalence of generalized acquired HSDD in women aged ≥18 who attended primary care or obstetrics and gynecology clinics for nonurgent clinic visits in the United States...
Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for womenRaymond C Rosen
Department of Epidemiology, New England Research Institutes Inc, Watertown, MA 02472, USA
Menopause 19:396-405. 2012..We examined the sociodemographic, relationship, help seeking, sexual function, and medical characteristics of women with a clinical diagnosis of generalized, acquired HSDD by menopause status...
Depression in premenopausal women with HSDD: baseline findings from the HSDD Registry for WomenAnita H Clayton
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia, USA
Psychosom Med 74:305-11. 2012..Data are from the HSDD Registry for Women, a large multicenter observational study of US women with clinically diagnosed generalized, acquired HSDD. We analyzed complete baseline data from 1088 premenopausal women...
Project VALOR: design and methods of a longitudinal registry of post-traumatic stress disorder (PTSD) in combat-exposed veterans in the Afghanistan and Iraqi military theaters of operationsRaymond C Rosen
New England Research Institutes, Inc, Watertown, MA 02472, USA
Int J Methods Psychiatr Res 21:5-16. 2012..Project VALOR is a unique and timely registry study that will evaluate the clinical course of PTSD, psychosocial correlates, and health outcomes in a carefully selected cohort of returning OEF/OIF Veterans...
Beyond the cluster: methodological and clinical implications in the Boston Area Community Health survey and EPIC studiesRaymond C Rosen
New England Research Institutes, Watertown, MA 02472, USA
BJU Int 101:1274-8. 2008....
Responsiveness and minimum important differences for the erection quality scaleRaymond C Rosen
Department of Psychiatry, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey, USA
J Urol 178:2076-81. 2007..We evaluated the responsiveness and treatment sensitivity of the Erection Quality Scale, and provided further psychometric validation of this scale...
Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasiaR Rosen
New England Research Institutes, Watertown, MA 2472, USA
Int J Impot Res 19:480-5. 2007..After 1 month of treatment, alfuzosin 10 mg q.d. significantly improved erectile function in men with lower urinary tract symptoms/ benign prostatic hypertrophy and had no adverse effect on ejaculatory function...
The Treatment Satisfaction Scale (TSS) is a sensitive measure of treatment effectiveness for both patients and partners: results of a randomized controlled trial with vardenafilRaymond Rosen
New England Research Institutes, 9 Galen Street, Watertown, MA 02472, USA
J Sex Med 4:1009-21. 2007..The ED Treatment Satisfaction Scale (TSS) is a brief, comprehensive self-report measure of patient and partner satisfaction...
Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunctionRaymond C Rosen
New England Research Institutes, Watertown, Massachusetts 02472, USA
Urology 69:805-9. 2007..An abridged version of the 25-item Male Sexual Health Questionnaire (MSHQ) was developed and validated (MSHQ-EjD Short Form) for assessing ejaculatory dysfunction (EjD)...
The COUPLES-project: a pooled analysis of patient and partner treatment satisfaction scale (TSS) outcomes following vardenafil treatmentRaymond C Rosen
New England Research Institutes, Watertown, MA, USA
BJU Int 99:849-59. 2007..To assess the influence of vardenafil on treatment satisfaction in men with erectile dysfunction (ED) and their female partners...
Correlates to the clinical diagnosis of premature ejaculation: results from a large observational study of men and their partnersRaymond C Rosen
New England Research Institutes, Watertown, Massachusetts 02472, USA
J Urol 177:1059-64; discussion 1064. 2007..In the current analysis we assessed the relative influence of those measures in identifying premature ejaculation as diagnosed by the clinician...
Normal sexual response in womenRaymond C Rosen
New England Research Institutes, 9 Galen Street, Watertown, MA 02472, USA
Obstet Gynecol Clin North Am 33:515-26. 2006..Promising efforts have been made in this regard, although much work remains to be done...
The Bolger conference on PDE-5 inhibition and HIV risk: implications for health policy and preventionRaymond C Rosen
Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, NJ, USA
J Sex Med 3:960-75; discussion 973-5. 2006..Recent reports have linked the use of phosphodiesterase type 5 (PDE-5) inhibitors with increased rates of high-risk sexual behavior and HIV transmission in some individuals...
Impact of premature ejaculation: the psychological, quality of life, and sexual relationship consequencesRaymond C Rosen
New England Research Institutes, Watertown, MA, USA
J Sex Med 5:1296-307. 2008..Premature ejaculation (PE) has been associated with a range of negative psychological effects, including anxiety, depression, and distress in men and their female partners...
Impact of Peyronie's disease on sexual and psychosocial functioning: qualitative findings in patients and controlsRaymond Rosen
New England Research Institutes, Watertown, MA 02472, USA
J Sex Med 5:1977-84. 2008..There are no validated scales for assessing the psychosocial impact of Peyronie's disease (PD), which affects approximately 5-10% of men over age 50...
Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH RegistryRaymond C Rosen
New England Research Institutes, Watertown, Massachusetts 02472, USA
Urology 73:562-6. 2009..ED and EjD are also side effects of some medical therapies for LUTS suggestive of benign prostatic hyperplasia (LUTS/BPH). These relationships were examined in a physician office-based population of men enrolled in the BPH Registry...
Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scaleRaymond C Rosen
New England Research Institutes, Inc, Watertown, MA 02472, USA
Eur Urol 60:1010-6. 2011....
The NERI Hypogonadism Screener: psychometric validation in male patients and controlsRaymond C Rosen
New England Research Institutes, Inc, 9 Galen Street, Watertown, MA 02472, USA
Clin Endocrinol (Oxf) 74:248-56. 2011..To present data on the quantitative validation of a new self-report instrument (HG Screener) developed to identify men with symptoms of HG...
Female Sexual Well-Being Scale: responsiveness to interventional product use by sexually functional womenRaymond C Rosen
New England Research Institutes, Watertown, MA 02472, USA
J Sex Med 7:2479-86. 2010..Initial psychometric evaluation of the Female Sexual Well-Being Scale(TM) (FSWB Scale(TM)) demonstrated its validity for assessing sexual well-being in sexually functional US women...
The HSDD registry for women: a novel patient registry for women with generalized acquired hypoactive sexual desire disorderRaymond C Rosen
New England Research Institutes, Inc, Watertown, MA 02472, USA
J Sex Med 7:1747-56. 2010..Hypoactive sexual desire disorder (HSDD) is a clinically challenging disorder in women. Little is known about the natural history of the disorder and long-term consequences. A longitudinal registry can address these needs...
Correlates of sexually related personal distress in women with low sexual desireRaymond C Rosen
New England Research Institutes, Watertown, MA 02472, USA
J Sex Med 6:1549-60. 2009..Sexual distress is an important component of diagnostic criteria for sexual dysfunctions, but little is known about the factors associated with sexual distress in women with low sexual desire...
Female sexual well-being scale (FSWB scale): development and psychometric validation in sexually functional womenRaymond C Rosen
New England Research Institutes, 9 Galen Street, Watertown, MA 02472, USA
J Sex Med 6:1297-305. 2009..No validated instrument exists for measuring female sexual well-being (FSWB) in women without medical/psychosocial conditions...
Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaRaymond C Rosen
New England Research Institutes, Watertown, MA 02472, USA
BJU Int 104:974-83. 2009....
Lower urinary tract symptoms and sexual health: the role of gender, lifestyle and medical comorbiditiesRaymond C Rosen
New England Research Institutes, Inc, Watertown, MA 02472, USA
BJU Int 103:42-7. 2009..To investigate the association between urological symptoms and self-reported measures of sexual activity, desire and function in large representative samples of men and women in the Boston Area Community Health (BACH) survey...
Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trialRaymond C Rosen
New England Research Institutes, 9 Galen Street, Watertown, MA, USA
J Sex Med 6:1414-22. 2009..Determinants of erectile dysfunction in diabetic men have not been adequately investigated as potential mediators of change...
Validated questionnaires for assessing sexual dysfunction and BPH/LUTS: solidifying the common pathophysiologic linkR C Rosen
New England Research Institutes, Watertown, MA 02472, USA
Int J Impot Res 20:S27-32. 2008....
Assessing symptoms of hypogonadism by self-administered questionnaire: qualitative findings in patients and controlsRaymond C Rosen
New England Research Institutes, Inc, Watertown, Massachusetts 02472, USA
Aging Male 12:77-85. 2009..A new self-administered questionnaire of hypogonadism symptoms is being developed to address this need. The process for questionnaire development and results from the first (qualitative) phase are presented...
Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration--results from the BACH SurveyVarant Kupelian
New England Research Institutes, Watertown, Massachusetts 02472, USA
J Urol 181:694-700. 2009..In addition, we determined whether a dose-response relationship exists in the association between the severity and duration of urological symptoms and major chronic illnesses...
Correlates of PDE5i use among subjects with erectile dysfunction in two population-based surveysThomas G Travison
Department of Epidemiology, New England Research Institutes, Inc, Watertown, MA 02472, USA
J Sex Med 8:3051-7. 2011..Less is known, however, concerning the influence of sociomedical factors such as income and body composition on receipt of treatment...
Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health surveyVarant Kupelian
New England Research Institutes, Watertown, Massachusetts, USA
Urology 73:950-7. 2009....
Nocturia and quality of life: results from the Boston area community health surveyVarant Kupelian
New England Research Institutes, Watertown, MA 02472, USA
Eur Urol 61:78-84. 2012..Nocturia, a common complaint in aging men and women, is frequently cited as the cause of nocturnal awakenings leading to sleep loss, daytime fatigue, and reduced quality of life (QOL)...
Association of nocturia and mortality: results from the Third National Health and Nutrition Examination SurveyVarant Kupelian
New England Research Institutes, Watertown, Massachusetts 02472, USA
J Urol 185:571-7. 2011..Using data from the Third National Health and Nutrition Examination Survey we investigated the association of nocturia with subsequent mortality risk...
Sexual arousal and lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for womenNancy N Maserejian
Department of Epidemiology, New England Research Institutes, Inc, Watertown, Massachusetts 02472, USA
J Sex Marital Ther 38:41-62. 2012..lubrication)...
Male Sexual Health Questionnaire (MSHQ): scale development and psychometric validationRaymond C Rosen
Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA
Urology 64:777-82. 2004..This new instrument has excellent psychometric properties and is well suited for use in clinical and research settings...
Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health surveyVarant Kupelian
New England Research Institutes, 9 Galen St, Watertown, MA 02472, USA
J Urol 189:S107-14; discussion S115-6. 2013....
Urological symptom clusters and health-related quality-of-life: results from the Boston Area Community Health SurveySusan A Hall
New England Research Institutes, Watertown, MA, USA
BJU Int 103:1502-8. 2009..CONCLUSION For men and women, those with the most urological symptoms reported poorer HRQoL in two domains after adjusting for age and comorbidity, and despite adequate access to care...
Prevalence and correlates of sexual activity and function in women: results from the Boston Area Community Health (BACH) SurveyKaren E Lutfey
New England Research Institutes, Watertown, MA 02472, USA
Arch Sex Behav 38:514-27. 2009..In terms of psychosocial factors, depression, sexual and physical abuse in adulthood, global mental health functioning, and alcohol were associated with sexual problems, with variation across racial/ethnic groups...
Sexual desire, distress, and associated factors in premenopausal women: preliminary findings from the hypoactive sexual desire disorder registry for womenMegan K Connor
New England Research Institutes, Watertown, Massachusetts 02472, USA
J Sex Marital Ther 37:176-89. 2011..The authors conclude that even among women with clinically diagnosed HSDD, the level of sexually related distress varies with situational factors, such as stress and fatigue...
International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculationStanley E Althof
Department of Psychiatry, University of Miami Miller School of Medicine, West Palm Beach, FL, USA
J Sex Med 7:2947-69. 2010....
PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomesRaymond C Rosen
UMDNJ Robert Wood Johnson Medical School, Department of Psychiatry, Piscataway, NJ 08854, USA
Annu Rev Sex Res 13:36-88. 2002..The potential impact on societal attitudes toward sexuality and sexual dysfunction also warrants consideration...
Sexual activity, erectile dysfunction, and incident cardiovascular eventsSusan A Hall
New England Research Institutes, Watertown, Massachusetts, USA
Am J Cardiol 105:192-7. 2010..45, 95% confidence interval 1.04 to 2.01). In conclusion, our results suggest that a low frequency of sexual activity predicts CVD independently of ED and that screening for sexual activity might be clinically useful...
Risk factors for incident erectile dysfunction among community-dwelling menSusan A Hall
Department of Epidemiology, New England Research Institute, Watertown, MA, USA
J Sex Med 7:712-22. 2010..Compared to the prevalence of erectile dysfunction (ED), fewer studies have focused on the incidence of ED and even fewer have focused on nonmedical risk factors...
Do urological symptoms cluster among women? Results from the Boston Area Community Health SurveySusan A Hall
New England Research Institutes, Watertown, MA 02472, USA
BJU Int 101:1257-66. 2008....
Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?Andre B Araujo
New England Research Institutes, Watertown, Massachusetts, USA
J Am Coll Cardiol 55:350-6. 2010..This study was designed to determine whether erectile dysfunction (ED) predicts cardiovascular disease (CVD) beyond traditional risk factors...
The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trialsRaymond C Rosen
Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA
Curr Med Res Opin 21:1701-9. 2005..001). CONCLUSIONS: Compared with placebo, tadalafil 10 mg and 20 mg improved overall satisfaction with the sexual experience, intercourse satisfaction, and intercourse enjoyment in men with mild, moderate, and severe ED...
Erectile dysfunction and mortalityAndre B Araujo
New England Research Institutes, Watertown, MA 02472, USA
J Sex Med 6:2445-54. 2009..Erectile dysfunction (ED) and cardiovascular disease (CVD) share pathophysiological mechanisms and often co-occur. Yet it is not known whether ED provides an early warning for increased CVD or other causes of mortality...
Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health SurveyVarant Kupelian
New England Research Institutes, Watertown, Massachusetts 02472, USA
J Urol 182:616-24; discussion 624-5. 2009....
An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonistLisa E Diamond
Palatin Technologies, Inc, Cranbury, NJ 08512, USA
J Sex Med 3:628-38. 2006....
Overview of phosphodiesterase 5 inhibition in erectile dysfunctionRaymond C Rosen
Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey 08854, USA
Am J Cardiol 92:9M-18M. 2003..These agents have demonstrated improvement in erectile function and have been shown to be well tolerated in diverse populations comprising thousands of men worldwide. Profiles of these 3 PDE5 inhibitors are reviewed herein...
Determining the earliest time within 30 minutes to erectogenic effect after tadalafil 10 and 20 mg: a multicenter, randomized, double-blind, placebo-controlled, at-home studyRaymond C Rosen
Robert Wood Johnson Medical School, Piscataway, NJ, USA
J Sex Med 1:193-200. 2004..Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor used for the treatment of erectile dysfunction (ED). The minimal time to onset of erectogenic effect in the at-home setting has not been evaluated...
Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS)Sandra R Leiblum
University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, Piscataway, 08854, USA
Menopause 13:46-56. 2006..To determine the prevalence of hypoactive sexual desire disorder (HSDD) among US women by reproductive status and age and to explore the correlates of sexually related distress...
The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general populationRaymond C Rosen
Department of Psychiatry, Robert Wood Johnson Medical School, Pisctaway, NJ 08854, USA
Curr Med Res Opin 20:607-17. 2004....
Cluster analysis and lower urinary tract symptoms in men: findings from the Boston Area Community Health SurveyAmy Cinar
New England Research Institutes, Watertown, MA 02472, USA
BJU Int 101:1247-56. 2008..To classify lower urinary tract symptoms (LUTS) in a large, representative sample of men in the USA by means of cluster analysis and to investigate risk factors and comorbidities associated with the resulting cluster patterns...
Relative contributions of modifiable risk factors to erectile dysfunction: results from the Boston Area Community Health (BACH) SurveyVarant Kupelian
New England Research Institutes, 9 Galen St, Watertown, MA 02472, USA
Prev Med 50:19-25. 2010..The objective of this study was to determine the relative contribution of modifiable risk factors (physical activity, smoking, and alcohol consumption) to inter-subject variation in erectile dysfunction (ED)...
Is hyperlipidemia or its treatment associated with erectile dysfunction?: Results from the Boston Area Community Health (BACH) SurveySusan A Hall
Department of Epidemiology, New England Research Institutes, Watertown, MA 02472, USA
J Sex Med 6:1402-13. 2009..Studies and reports suggest that both hyperlipidemia and its pharmacologic treatment may lead to an increased risk of erectile dysfunction (ED)...
The presentation of hypoactive sexual desire disorder in premenopausal womenNancy N Maserejian
New England Research Institutes, Inc, Watertown, MA 02472, USA
J Sex Med 7:3439-48. 2010..Little is known about the clinical presentation of hypoactive sexual desire disorder (HSDD) in premenopausal women or their perceptions of sexual problems...
An examination of the association of abuse (physical, sexual, or emotional) and female sexual dysfunction: results from the Boston Area Community Health SurveyKaren E Lutfey
New England Research Institutes, Watertown, Massachusetts 02472, USA
Fertil Steril 90:957-64. 2008..To examine associations between abuse (physical, sexual, and emotional) in childhood and adolescence/adulthood and sexual activity and dysfunction in women...
Sexual dysfunction and chronic illness: the role of flexibility in copingJennifer L Barsky
Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA
J Sex Marital Ther 32:235-53. 2006..We describe how this model can be applied in a comprehensive approach to treating sexual dysfunction in individuals with chronic illnesses...
Association of overactive bladder and C-reactive protein levels. Results from the Boston Area Community Health (BACH) SurveyVarant Kupelian
New England Research Institutes, Watertown, MA 02472, USA
BJU Int 110:401-7. 2012..To investigate the association between overactive bladder (OAB) and C-reactive protein (CRP) in a population-based sample of men and women...
Socioeconomic status, not race/ethnicity, contributes to variation in the prevalence of erectile dysfunction: results from the Boston Area Community Health (BACH) SurveyVarant Kupelian
New England Research Institutes, Watertown, MA, USA
J Sex Med 5:1325-33. 2008..Few population-based studies have assessed variations in the burden of erectile dysfunction (ED) by race/ethnicity...
Minimal clinically important differences in the vaginal insertion and successful intercourse items of the sexual encounter profileAndre B Araujo
New England Research Institutes, Inc, Watertown, MA 02472, USA
J Sex Med 9:169-79. 2012....
Assessment of sexual dysfunction in patients with benign prostatic hyperplasiaRaymond C Rosen
UMDNJ Robert Wood Johnson Medical School, Piscataway, NJ, USA
BJU Int 97:29-33; discussion 44-5. 2006..The MSHQ scale has excellent psychometric properties and is well suited for use in clinical and research settings. A short form of the MSHQ scale is currently under development...
Menopausal Sexual Interest Questionnaire (MSIQ): a unidimensional scale for the assessment of sexual interest in postmenopausal womenRaymond C Rosen
Robert Wood Johnson Medical School, Piscataway, New Jersey, USA
J Sex Marital Ther 30:235-50. 2004..The MSIQ demonstrated adequate construct validity, with all three domains showing a high degree of sensitivity and with two of the three exhibiting specificity to the effects of treatment...
Healthcare utilization in women diagnosed with hypoactive sexual desire disorder: interim baseline results from the HSDD Registry for WomenNancy Nairi Maserejian
New England Research Institutes, Inc, Watertown, Massachusetts 02472, USA
J Womens Health (Larchmt) 19:2001-9. 2010..To investigate treatment seeking and utilization of women diagnosed with hypoactive sexual desire disorder (HSDD) in the clinical setting...
Sexual desire and the female sexual function index (FSFI): a sexual desire cutpoint for clinical interpretation of the FSFI in women with and without hypoactive sexual desire disorderEric P Gerstenberger
New England Research Institutes, Inc, Watertown, MA 02472, USA
J Sex Med 7:3096-103. 2010..However, there is no sexual desire (SD) domain-specific cutpoint for assessing the presence of diminished desire in women with or without a sexual desire problem...
Research instruments for the diagnosis and treatment of patients with erectile dysfunctionRaymond C Rosen
Department of Psychiatry, Center for Sexual and Marital Health, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854 5635, USA
Urology 68:6-16. 2006..We provide a summary of some of the most commonly used instruments for the diagnosis and assessment of ED treatment efficacy that will be referred to in this supplement...
The natural progression and regression of erectile dysfunction: follow-up results from the MMAS and MALES studiesThomas G Travison
Department of Medicine, Boston University, Boston, MA, USA
J Sex Med 8:1917-24. 2011..These results have not been replicated using more recent data-relevant in light of the introduction of phosphodiesterase type 5 inhibitors (PDE5i) to treat ED-nor compared with those from other populations...
Depression and sexual functioning in minority women: current status and future directionsRoseanne DeFronzo Dobkin
Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, 08855, USA
J Sex Marital Ther 32:23-36. 2006..Further research emphasizing gender and culture is needed to elucidate the prevalence, impact, and treatment of sexual dysfunction in specific groups of depressed minority women...
Prevalence of antidepressant-associated erectile dysfunctionRaymond C Rosen
Department of Psychiatry, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, NJ 08554 5653, USA
J Clin Psychiatry 64:5-10. 2003..Treatment of antidepressant-associated erectile dysfunction can greatly increase the likelihood that patients will continue the medication that effectively treats their depression...
Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factorsRaymond C Rosen
Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA
Urol Clin North Am 32:403-17, v. 2005..Lifestyle factors, including obesity and exercise frequency, also have been implicated in recent studies...
Erectile dysfunction and cardiac disease: recommendations of the Second Princeton ConferenceRaymond C Rosen
University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, 671 Hoes Lane, Piscataway, NJ 08854, USA
Curr Urol Rep 7:490-6. 2006..Other drug interactions and the cardiovascular safety of testosterone replacement therapy are considered...
Lifestyle management of erectile dysfunction: the role of cardiovascular and concomitant risk factorsRaymond C Rosen
Department of Psychiatry, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA
Am J Cardiol 96:76M-79M. 2005..Taken together, these studies support the value of risk factor modification and lifestyle change in the clinical management in men with ED and concomitant cardiovascular illness...
Sexual function assessment and the role of vasoactive drugs in female sexual dysfunctionRaymond C Rosen
Department of Psychiatry, UMDNJ Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA
Arch Sex Behav 31:439-43. 2002..Clinical trials in this area should also make use of the new consensus classification system for female sexual dysfunction in determining inclusion and exclusion criteria for the trial...
Reproductive health problems in ageing menRaymond C Rosen
UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA
Lancet 366:183-5. 2005
Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)Raymond C Rosen
Department of Psychiatry, UMDNJ Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, NJ 08854, USA
Eur Urol 47:824-37. 2005..For men with LUTS and sexual dysfunction, an appropriate integrated management approach, based on each patient's symptoms and outcome objectives, is warranted...
The prevalence of sexual problems in women: how valid are comparisons across studies? Commentary on Bancroft, Loftus, and Long's (2003) 'distress about sex: a national survey of women in heterosexual relationships"Raymond C Rosen
Department of Psychiatry, Robert Wood Johnson Medical School UMDNJ, Piscataway, New Jersey 08854, USA
Arch Sex Behav 32:209-11; discussion 213-6. 2003
Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasiaRaymond C Rosen
Department of Psychiatry, UMDNJ Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA
Curr Opin Urol 16:11-9. 2006..Recent evidence of an association between LUTS/BPH and sexual dysfunction will be reviewed, as well as the effects of pharmacological treatment options for symptomatic LUTS/BPH on sexual function...
Evaluation of the patient with erectile dysfunction: history, questionnaires, and physical examinationRaymond C Rosen
Department of Psychiatry, UMDNJ Robert Wood Johnson Medical School, Piscataway, NJ, USA
Endocrine 23:107-11. 2004..New management guidelines emphasize the need for a brief sexual and medical history, physical examination, and standard laboratory tests to rule out diabetes, dyslipidemia, or hypogonadism...
Assessment of female sexual dysfunction: review of validated methodsRaymond C Rosen
Department of Psychiatry, UMDNJ Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA
Fertil Steril 77:S89-93. 2002..To review validated methods for the assessment of female sexual function in clinical trials...
Vasomax for the treatment of male erectile dysfunctionI Goldstein
Boston University School of Medicine, Department of Urology, MA, USA
World J Urol 19:51-6. 2001..Results of clinical trials with Vasomax support the concept of adrenergic-blockade as a clinically relevant mechanism in the control of penile erection...
The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicineGraham Jackson
Cardiothoracic Center, St Thomas Hospital, London, UK
J Sex Med 3:28-36; discussion 36. 2006..The first Princeton Consensus Conference (Princeton I) in 1999 developed guidelines for safe management of cardiac patients regarding sexual activity and the treatment of ED...
Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) studyWilliam A Fisher
Department of Psychology, Social Science Centre 6430, University of Western Ontario, London, Ontario, Canada N6A 5C2
J Sex Med 2:675-84. 2005..Much research has explored the experience of erectile dysfunction (ED) among men with ED, but far less attention has been paid to the perceptions and sexual experiences of the female partners of men with ED...
Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trialIrwin Goldstein
J Sex Med 2:819-32. 2005..There are limited data concerning the sexual function of women whose male partners receive pharmacological treatment for erectile dysfunction (ED)...
Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafilWilliam A Fisher
Department of Psychology, Social Science Centre 6430, University of Western Ontario, London, Ontario, Canada N6A 5C2
J Sex Med 2:699-708. 2005....
Oral sildenafil in the treatment of erectile dysfunction. 1998Irwin Goldstein
J Urol 167:1197-203; discussion 1204. 2002
Development of a sexual function questionnaire for clinical trials of female sexual dysfunctionFrances H Quirk
Pfizer Global Research and Development, Pfizer Ltd, Sandwich, Kent, UK
J Womens Health Gend Based Med 11:277-89. 2002..The results suggest that the SFQ may be a valuable new tool for evaluating and diagnosing subsets of FSD and, ultimately, for evaluating treatments of these disorders...
The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunctionWilliam A Fisher
Department of Psychology, Social Science Centre 6430, University of Western Ontario, Canada
J Sex Med 1:150-60. 2004..The aim of Phase II of the Men's Attitudes to Life Events and Sexuality (MALES) Study is to explore PDE5 inhibitor treatment seeking among men with erectile dysfunction (ED)...
Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice settingMICHAEL P O'LEARY
Harvard Medical School, Brigham and Women s Hospital, Boston, MA 02115, USA
BJU Int 101:1531-5. 2008....
An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculationChris G McMahon
Australian Center for Sexual Health, Sydney, Australia
J Sex Med 5:1590-606. 2008....
Sexual and relationship characteristics among an internet-based sample of U.S. men with and without erectile dysfunctionAnn Cameron
Outcomes Research, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
J Sex Marital Ther 31:229-42. 2005..Sexual function and relationship and psychological characteristics were significant predictors of overall sexual satisfaction and relationship satisfaction...
Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunctionRidwan Shabsigh
Department of Urology, Columbia-Presbyterian Medical Center, New York, New York 10032, USA
Urology 68:689-96. 2006
Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: results of a multicenter, randomized, open-label, crossover studyJohn Dean
The Prostate Center, London, UK
J Sex Med 3:650-61. 2006..Although sildenafil citrate (sildenafil) and tadalafil are efficacious and well-tolerated treatments for erectile dysfunction (ED), preference studies have shown that patients may favor one medication over the other...
Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trialsJon L Pryor
University of Minnesota, Minneapolis, MN 55455, USA
Lancet 368:929-37. 2006..No drugs are approved for treatment of premature ejaculation. Our aim was to determine the efficacy and tolerability of on-demand dapoxetine in patients with severe premature ejaculation...
Comment: neurologic, psychological, and aggressive disturbances with sildenafilRaymond C Rosen
Ann Pharmacother 36:1973-4; author reply 1974. 2002
Effective treatment of erectile dysfunction with vardenafilAntonio Martin-Morales
Unidad de Andrologia, Complejo Hospitalario Carlos Haya, Malaga, Spain
Drugs Today (Barc) 39:51-9. 2003..Vardenafil, a new phosphodiesterase type 5 inhibitor, is an agent which has shown promise at each stage of development. The drug is currently in the third phase of clinical testing for the treatment of erectile dysfunction...
The psychological and interpersonal relationship scales: assessing psychological and relationship outcomes associated with erectile dysfunction and its treatmentRalph W Swindle
Outcomes Research, Eli Lilly and Company, Indianapolis, Indiana, USA
Arch Sex Behav 33:19-30. 2004..It provides a broader assessment of treatment outcome than current measures of erectile function...
Female sexuality and sexual dysfunctionIrwin Goldstein
Arch Sex Behav 31:391. 2002
Current perspectives on the clinical assessment and diagnosis of female sexual dysfunction and clinical studies of potential therapies: a statement of concernStanley E Althof
Department of Psychology, Case Western Reserve University School of Medicine, Cleveland, OH, USA
J Sex Med 2:146-53. 2005..The assessment and diagnosis of female sexual dysfunction (FSD) are in a state of transition because of evolving concepts of female sexuality and suggested changes to the FSD diagnostic framework...
Summary of the recommendations on sexual dysfunctions in menTom F Lue
Department of Urology, UCSF, San Francisco, CA, USA
J Sex Med 1:6-23. 2004..Disorders of sexual function in men include erectile dysfunction, orgasm/ejaculation disorders, priapism, and Peyronie's disease...
Research Grants
- Sexual Dysfunction: Effects of Weight-LossRaymond Rosen; Fiscal Year: 2003..Additionally, the proposed study will provide data on the relationship between sexual function outcomes and other key measures of mood state and quality of life in the main Look AHEAD trial. ..
- PDE-5 Inhibition in HIV+ and HIV- MenRaymond Rosen; Fiscal Year: 2005..Key personnel for the project are Raymond C. Rosen, Ph.D., Professor of Psychiatry and Medicine at UMDNJ, who will serve as PI, and Joseph Catania, PhD, co-PI, from the AIDS Research Institute at UCSF. ..
- Sexual Dysfunction and Diabetes:Look AHEAD Sub-StudyStephen Schneider; Fiscal Year: 2006..iii) Finally, the proposed sub-study will investigate the relationship between changes in sexual function and quality of life outcomes. ..
